tiprankstipranks
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Hong Kong Market
Want to see HK:2157 full AI Analyst Report?

Lepu Biopharma Co. Ltd. Class H (2157) Financial Statements

4 Followers

Lepu Biopharma Co. Ltd. Class H Financial Overview

Lepu Biopharma Co. Ltd. Class H's market cap is currently HK$9.20B. The company's EPS TTM is HK$0.14; its P/E ratio is 9.33; Lepu Biopharma Co. Ltd. Class H is scheduled to report earnings on March 25, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 910.67M¥ 367.79M¥ 225.35M¥ 15.57M¥ 0.00
Gross Profit¥ 732.10M¥ 292.97M¥ 197.07M¥ 13.57M¥ 0.00
Operating Income¥ 87.43M¥ -390.76M¥ 4.80M¥ -704.48M¥ -1.01B
EBITDA¥ 178.73M¥ -311.94M¥ 86.95M¥ -596.53M¥ -865.23M
Net Income¥ 254.60M¥ -411.38M¥ -22.10M¥ -689.05M¥ -1.01B
Balance Sheet
Cash & Short-Term Investments¥ 959.17M¥ 464.91M¥ 489.64M¥ 678.20M¥ 205.17M
Total Assets¥ 3.10B¥ 2.28B¥ 2.38B¥ 2.53B¥ 2.08B
Total Debt¥ 1.06B¥ 850.16M¥ 746.82M¥ 690.30M¥ 335.26M
Net Debt¥ 205.13M¥ 448.88M¥ 320.81M¥ 20.91M¥ 180.09M
Total Liabilities¥ 1.72B¥ 1.60B¥ 1.50B¥ 1.63B¥ 1.23B
Stockholders' Equity¥ 1.39B¥ 702.83M¥ 896.90M¥ 900.76M¥ 836.71M
Cash Flow
Free Cash Flow¥ -82.80M¥ -258.14M¥ -292.04M¥ -591.38M¥ -835.12M
Operating Cash Flow¥ -38.56M¥ -196.39M¥ -250.84M¥ -480.93M¥ -621.74M
Investing Cash Flow¥ -149.19M¥ -61.75M¥ 18.26M¥ -74.66M¥ -3.89M
Financing Cash Flow¥ 620.94M¥ 232.08M¥ -11.01M¥ 1.03B¥ 380.31M
Currency in CNY

Lepu Biopharma Co. Ltd. Class H Earnings and Revenue History

Lepu Biopharma Co. Ltd. Class H Debt to Assets

Lepu Biopharma Co. Ltd. Class H Cash Flow

Lepu Biopharma Co. Ltd. Class H Forecast EPS vs Actual EPS